GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

No trades
See on Supercharts
Market capitalization
‪80.28 B‬USD
0.49USD
‪2.92 B‬USD
‪35.61 B‬USD
Beta (1Y)
−0.04

About GSK plc


CEO
Emma N. Walmsley
Website
Headquarters
London
ISIN
ARDEUT110483
FIGI
BBG003641Z45
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Check out other big names from the same industry as GSKC.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.
GSK.GJ
GlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
Yield to maturity
Maturity date
May 15, 2038
GSK6023693
GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
Yield to maturity
Maturity date
Apr 15, 2035
GSK6023691
GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
Yield to maturity
Maturity date
Mar 12, 2027
GSK6023695
GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
Yield to maturity
Maturity date
Apr 15, 2030
GSK3981911
GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
Yield to maturity
Maturity date
Mar 18, 2043
GSK6023692
GlaxoSmithKline Capital Plc FRN 12-MAR-2027
Yield to maturity
Maturity date
Mar 12, 2027
GX5B
GlaxoSmithKline Capital Plc 1.0% 12-SEP-2026
Yield to maturity
Maturity date
Sep 12, 2026
XS255381768
GSK Capital BV 3.0% 28-NOV-2027
Yield to maturity
Maturity date
Nov 28, 2027
US377372AN7
GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028
Yield to maturity
Maturity date
May 15, 2028
XS293369143
GSK Capital BV 2.875% 19-NOV-2031
Yield to maturity
Maturity date
Nov 19, 2031
XS217060184
GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028
Yield to maturity
Maturity date
Oct 12, 2028

See all GSKC bonds 

Curated watchlists where GSKC is featured.